The company successfully broke through the technical bottleneck of industrialization of starch plants capsule, a new auxiliary material, and integrated domestic and foreign resources. Through a series of layouts, a complete industrial chain from upstream raw material production and processing, technical services, logistics and warehousing to terminal sales services has been established, making it the first cassava starch capsule industrialization enterprise in the world. Completed the registration of FDA in the United States and the filing of DMF, obtained the halal certification issued by ANCA, the kosher certification of KOFK and the hala certification of Indonesia, and seized the international commanding heights of this product. At present, the company has formed a new pattern of all-round development with pharmaceutical excipients as the mainstay, and three series of products of raw materials and finished drugs go hand in hand. The company has 15 offices and distribution logistics centers all over the country, covering more than 30 provinces, municipalities, autonomous regions, Southeast Asia, Europe and the United States, and can provide customers with one-stop services.
In the future, the company will focus on pharmaceutical excipients with starch capsules as the core, health care products and pharmaceutical preparations with starch capsules as the carrier, take the revitalization of the national pharmaceutical industry as its own responsibility, base itself on China and face the world, and open up a new blue ocean for enterprise development through continuous research and development and innovation.